Intricon Corp
NASDAQ:IIN
Relative Value
There is not enough data to reliably calculate the relative value of IIN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
IIN Competitors Multiples
Intricon Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Intricon Corp
NASDAQ:IIN
|
225.2m USD | 1.8 | -152.2 | 28.4 | 125.4 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183B USD | 4.5 | 32.4 | 19.2 | 28.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.6B USD | 18 | 66.4 | 54.3 | 68.1 | ||
US |
Stryker Corp
NYSE:SYK
|
123.8B USD | 5.9 | 36.8 | 24 | 29.5 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.8B USD | 3.3 | 25.6 | 13.7 | 19.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
104.8B USD | 7.1 | 59.4 | 30.3 | 44.7 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.9B USD | 3.5 | 56.5 | 18.9 | 39.9 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.2B EUR | 2.6 | 37.7 | 18.2 | 30.6 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.1B USD | 8.3 | 36.1 | 26.2 | 28.4 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49.6B USD | 13.1 | 77.7 | 58 | 75.5 |